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Abstract 
Glioblastoma (GBM) is a lethal primary brain tumor characterized by treatment 
resistance and inevitable tumor recurrence, both of which are driven by a 
subpopulation of GBM cancer stem-like cells (GSC) with tumorigenic and self-
renewal properties. Despite having broad implications for understanding GSC 
phenotype, the determinants of upregulated DNA damage response (DDR) and 
subsequent radiation resistance in GSC are unknown and represent a significant 
barrier to developing effective GBM treatments. In this study, we show that 
constitutive DDR activation and radiation resistance are driven by high levels of DNA 
replication stress (RS). CD133+ GSC exhibited reduced DNA replication velocity and 
a higher frequency of stalled replication forks than CD133- non-GSC in vitro; 
immunofluorescence studies confirmed these observations in a panel of orthotopic 
xenografts and human GBM specimens. Exposure of non-GSC to low-level 
exogenous RS generated radiation resistance in vitro, confirming RS as a novel 
determinant of radiation resistance in tumor cells. GSC exhibited DNA double strand 
breaks (DSB) which co-localized with 'replication factories' and RNA: DNA hybrids. 
GSC also demonstrated increased expression of long neural genes (>1Mbp) 
containing common fragile sites, supporting the hypothesis that 
replication/transcription collisions are the likely cause of RS in GSC. Targeting RS by 
combined inhibition of ATR and PARP (CAiPi) provided GSC-specific cytotoxicity 
and complete abrogation of GSC radiation resistance in vitro. These data identify RS 
as a cancer stem cell-specific target with significant clinical potential. 
Significance 
Findings shed new light on cancer stem cell biology and reveal novel therapeutics 
with the potential to improve clinical outcomes by overcoming inherent 
radioresistance in GBM. 
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Introduction 
Despite detailed characterization of the genomic and molecular landscape of 
glioblastoma (GBM) life expectancy for patients with this aggressive tumor remains 
extremely poor (1, 2). Standard of care comprises neurosurgical resection followed 
by treatment with radiotherapy and temozolomide, both of which are DNA damaging 
agents (3). Accumulating evidence suggests that the inevitable recurrence of GBM 
after chemoradiation is driven largely by GBM cancer stem-like cells (GSC), which 
drive resistance to DNA damaging therapies through constitutive up regulation of the 
DNA damage response (DDR) (4-6). This DDR phenotype has also been reported in 
cancer stem cells derived from other tumor types (7, 8) and in murine embryonic 
stem cells (9). Despite a decade of research, however, the underlying cause of DDR 
up regulation in GSC remains unclear. While an association with elevated levels of 
reactive oxygen species (ROS) has been reported (10), other studies have attributed 
radiation resistance to reduced levels of ROS in cancer stem cells (11). 
 
A consistent feature of the GSC and cancer stem cell DDR phenotype is the up 
regulation and/or constitutive activation of multiple components of both the DNA 
repair and cell cycle checkpoint pathways (4, 12). Previously, we demonstrated the 
therapeutic relevance of this phenotype by showing that inhibition of both DNA repair 
and cell cycle checkpoint function was required to overcome radioresistance (12). 
While several other reports have confirmed the radiosensitizing potential of DDR 
inhibition at the pre-clinical level (10, 13) progression to the clinic has been 
frustratingly slow. The aim of this study was to elucidate the mechanisms underlying 
constitutive DDR activation in GSC and use this knowledge to identify new 
therapeutic strategies for this cancer of unmet need. Our approach was informed by 
previous studies describing elevated levels of DNA replication stress (RS) in glioma 
specimens, particularly GBM (14), and by emerging evidence that RS can activate a 
broader spectrum of DDR proteins than previously thought (15). RS can be defined 
as inefficient DNA replication that causes replication forks to progress slowly or stall, 
and may be caused by a wide variety of cellular and environmental factors (16, 17). 
Because replication stress can have adverse consequences including permanent 
DNA damage and genomic instability, it evokes a spectrum of cellular responses that 
act to stabilize stalled forks and reduce the risk of fork collapse and consequent DNA 
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damage. Extensive overlap between the cellular responses to RS and radiation 
induced DNA damage supports the hypothesis that constitutive RS might be 
responsible for radiation resistance. 
 
A further question is whether GSC arise from neural progenitor cells, or are the 
product of de-differentiation of malignant glioma cells (18). Embedded within this 
controversy is the related question of whether neural progenitor cells are the cell of 
origin of GBM (19). The recently published observation that neural progenitor cells 
are prone to acquisition of DNA double strand breaks (DSB) at specific chromosomal 
sites as a consequence of RS induced by transcription of long neural genes (20) 
strengthens the rationale for exploring RS in GSC with a view to exploring a potential 
phenotypic link between these two cell populations. 
 
In this study, we demonstrate that GSC exhibit constitutively elevated RS both in 
vitro and in vivo, and that S phase GSC exhibit increased levels of DSB which arise 
at DNA ‘replication factories’. We show that exposure to exogenous RS generates 
significant radiation resistance in relatively radiosensitive non-GSC glioma cells. We 
provide evidence to support the hypothesis that RS and consequent activation of the 
DDR is associated with marked overexpression of very long genes, of which the 
most profoundly up regulated are the long neural genes previously shown to harbor 
DSB in neural stem cells (20). Finally, we show that targeting the RS response 
through combined ataxia telangiectasia and rad3 related protein (ATR) inhibition and 
poly (ADP-ribose) polymerase (PARP) inhibition (CAiPi) is an effective approach to 
overcoming the intrinsic radiation resistance of GSC. 
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Materials and Methods 
Derivation and maintenance of primary GBM cell lines 
Primary GBM cell lines E2, G7, R10, R15, R24, R9, S2 were derived from resected 
tumors and maintained as described previously (12, 21), approved by the local 
regional Ethics Committee (LREC ref 04/Q0108/60) in compliance with the UK 
Human Tissue Act 2004 (HTA License ref 12315). Tumorigenicity of paired GSC and 
differentiated GBM cell lines has been described previously (12, 21), (summarized in 
Supplemental table 1). Cell lines were utilized for 20 passages from thaw prior to 
being discarded and were tested for the presence of mycoplasma using the Lonza 
MycoAlert (LT07-318) assay on a 3 monthly basis. 
Immunohistochemistry/immunofluorescence on tissue sections 
Immunofluorescence microscopy on paraffin embedded sections was carried out as 
described previously (22).  Following antigen retrieval sections were incubated 
sequentially with primary and secondary antibodies (Supplemental tables 2 and 3). 
Immunofluorescence images were acquired as Z stacks with a Zeiss 780 confocal 
microscope and processed using maximum intensity projection (MIP) method where 
individual nuclei were selected and quantified for mean fluorescent intensity (MFI) 
values using ImageJ.  Sox2 high and low values were characterized as being above 
and below the median Sox2 MFI value in the whole imaged cell population 
respectively with the MFI of RPA32 being compared between the two groups. A 
minimum of 150 (range 150-700) nuclei per sample were quantified from 6-12 63x 
magnification fields. Non fluorescent immunohistochemistry slides were imaged 
using a Leica Slidepath system.   
Clonogenic and neurosphere assays 
Clonogenic survival assays were performed as described previously (12, 23).  Cells 
were treated with DDR inhibitors or DMSO for 1 hour followed by mock or 1-5 Gy 
irradiation. Cells were then incubated for a further 24 hours followed by replacement 
with fresh media without DDR inhibitor. Cell cultures were incubated with aphidicolin 
(Sigma) 0.05 µM (or DMSO) for 72 hours then plated in media with no added 
aphidicolin and irradiated 1 hour after plating.  Colonies were fixed in methanol after 
2-3 weeks, stained with crystal violet and counted manually. Clonogenic survival 
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data were fitted using a linear quadratic model and DMF 0.37 and SER 0.37 values 
were calculated from the fitted curve.  Significance between survival curves was 
assessed by two way ANOVA. 
For neurosphere assay 10 GSC were seeded into each well of a 96 well plate in 100 
µL medium containing 1 µM Olaparib and/or 5 µM  VE821 or DMSO control for 48 
hours or irradiated with 2 Gy ionizing irradiation, followed by the addition of 150 µL of 
fresh media per well. Neurospheres were manually counted under 5x magnification 
after 3-4 weeks. 
Flow cytometry and cell viability 
CD133+ and CD133– populations were isolated using a FACSAria fusion platform 
following labeling with CD133 phycoerythrin (PE) conjugated antibody. Live cells 
were gated (Supplementary figure 1A) and sorted populations were grown in 
identical stem cell culture media for 3 to 7 days prior to harvesting. 
Levels of ROS were measured using dichloro-dihydro-fluorescein diacetate 
(DCFDHA) OxiSelect™ In Vitro ROS Assay Kit according to manufacturer’s protocol 
(Cell Bio Labs Inc.).  Briefly, bulk and GSC were harvested and incubated in PBS 
containing DCFDHA at 37oC for 20 minutes.  Samples were washed twice in PBS 
followed by flow cytometry analysis of live cells.  Dead cells were excluded using 
DAPI. 
Cell cycle analysis using BrdU was carried out as described previously (12).  Briefly, 
bulk and GSC were incubated with 10 µM BrdU for 35 minutes.  Cells were washed 
in PBS and fixed in 70% ethanol. Samples were co-stained with anti-BrdU-FITC 
antibody (BD Bioscience) and propidium iodide.  Flow cytometry data was collected 
using FACSVerse (BD Biosciences) following doublet discrimination and analyzed 
using FlowJo software (Tristar). 
Cell viability was carried out using CellTiter-Glo® according to manufacturer’s 
protocol (Promega).  Briefly, bulk cells and GSC were plated out in 96 well plates 
and treated with Olaparib (1 µM) and VE821 (1, 3 or 5 µM) for 24 hours or 6 days, 
replaced with fresh media and cultured for a further 5 days followed by followed by 
detection of luminescence (Promega GLOMAX). 
In vitro immunofluorescence  
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Paired bulk and GSC were plated on coverslips coated with Matrigel. For BrdU 
studies, sub confluent paired bulk and/or GSCs were cultured on coverslips and 
pulse labelled with 10µM of BrdU for 30 minutes followed by fixation in 4% 
formaldehyde. Immunofluorescent visualization of RPA and pATM s1981 required 
removal of non-chromatin bound nuclear protein using an extraction buffer (24).   
Coverslips were washed in PBS and denatured in 2M HCl followed by 
immunostaining with anti-BrdU and γ-H2AX antibodies. For DDR inhibition studies, 
sub confluent cells were incubated with Olaparib and/or VE821 for 24 hours and 
fixed in 4% formaldehyde.  Cells were incubated with anti-γ-H2AX, BrdU, RPA 32 
and 53BP1 antibodies overnight at 4oC followed by incubation with secondary 
conjugated antibodies (Supplemental tables 2 and 3). Nuclei were counterstained 
with Vectashield mount containing DAPI.  Z-stack images were acquired under 
identical parameters using Zeiss LSM 780 confocal microscope and analyzed using 
Zen 2012 (Zeiss).  Co-localization was carried out using Zen Black software (Zeiss) 
from Z-stack images obtained at 40x magnification on a Zeiss 780 confocal 
microscope.  Co-localization coefficients defined as the relative number of BrdU 
pixels that co-localizes with γ-H2AX pixels or relative number of γ-H2AX pixels that 
co-localize with S9.6 pixels; value range 0-1 where 0 denotes no co-localization and 
1 represents all pixels co-localized and expressed as a percentage. 50-75 BrdU 
positive or 50-100 drug treated cells were analyzed and each experiment was 
repeated at least three times. 
DNA fiber assays 
DNA fiber assays were performed as described previously (15).  Briefly, cultured 
cells were incubated for 20 minutes with media containing CIdU (25µM) followed by 
PBS wash and incubation with media containing IdU (250µM). Cell suspensions 
were pipetted onto glass microscopy slides and lysed. Slides were raised to an angle 
of 300 in order to stretch DNA fibers along the slide. Immunostaining was then 
performed. CIdU was detected using anti BrdU (rat) primary antibody (Abcam 
ab6326 1:400) and anti-rat alexa fluorophore 555 (Invitrogen A21434 1:500) 
secondary. IdU was detected using anti BrdU (mouse) primary antibody (BD 347580 
1:500) and anti-mouse alexa fluorophore 488 (Invitrogen A11017 1:500). 
Drug treatment and radiation 
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ATR inhibitor VE821 (Vertex Pharmaceuticals) and PARP inhibitor olaparib 
(Selleckchem) were dissolved in DMSO and used at concentrations stated. A 
concentration of 5µM VE821 was found to be sufficient to inhibit phosphorylation of 
Chk1s345 following 5Gy radiation (Supplementary figure 1B). An XStrahl RS225 
cabinet at room temperature with 195 kV/15 mA X rays producing a dose rate of 1.6 
Gy per minute was utilized for in vitro radiation studies.  For UV studies, media was 
removed and cells were irradiated with 10 JM-2 UV (Stratalinker, Stratagene). 
Western blotting 
Western blotting was carried out as described previously (23). 
RNA sequencing and bioinformatics 
Total RNA was extracted from 7 paired bulk and GSC followed by generation of 
TruSeq Stranded mRNA library. Samples were run on four V3 flow cells with seven 
indexes per lane and sequenced on an Illumina HiSeq 2000™ to generate 30-45 M 
100 paired-end reads (supplementary materials and methods). RNA-sequencing 
data files were quality checked using FastQC and FastQ-Screen 
(www.bioinformatics.babraham.ac.uk). RNA-sequencing reads were aligned to the 
GRCh37 version of the human genome (25) using Tophat2 version 2.0.10 (26) with 
Bowtie version 2.1.0 (27). Relative expression levels were determined and 
statistically analyzed by a combination of HTSeq and the R 3.0.2 environment, 
utilising packages from the Bioconductor data analysis suite and differential gene 
expression analysis based on the negative binomial distribution using the DESeq 
package (28).  
Statistical Analyses 
All experiments were repeated and data points reported as mean +/- SEM. 
Correlation of Sox2 and RPA32 integrated density was performed using Spearman 
ranks due to non-normal distribution of these variables. Two way ANOVA was 
utilized in analyses of clonogenic survival curves. Means compared by unpaired 
students’ t-test. Medians were compared by Mann Whitney U test. Statistical 
analysis and graphs were produced using Minitab 16 and Graphpad Prism 6.  
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Results 
 
Radioresistant GSC demonstrate up regulation of DNA replication stress 
response markers  
We previously characterized constitutive DDR activation and associated 
radioresistance of GSC in a panel of primary GBM cell lines propagated as paired 
GSC-enriched (‘GSC’) and GSC-depleted (‘bulk’) cultures (12, 23, 29). Increased 
expression of the GSC markers Nestin and Sox2 along with constitutive up 
regulation and activation of the DDR proteins Chk1 and ATR were confirmed in GSC 
cultures by Western blot (Figure 1A). Using a DCFHDA assay no significant 
differences in baseline ROS levels between GSC and tumor bulk cultures were 
observed (Figure 1B), so alternative mechanisms to explain the up regulated DDR in 
GSC were investigated. The consistent pattern of robust up regulation of 
phosphorylated ATR (Ser428) and phosphorylated CHK1 (Ser345) in GSC cultures 
(Figure 1A) led us to hypothesize that GSC populations might exhibit high levels of 
RS. Replication protein A (RPA) binds single stranded DNA (ssDNA) adjacent to 
collapsed or stalled replication forks and is necessary for the activation of ATR 
kinase in the cellular response to RS (30). Validation of the RS phenotype was 
therefore sought by probing for phosphorylation of RPA subunit 32 (RPA32) at Ser4 
and Ser8, which is a specific marker of RS (31). While phospho-RPA32 (Ser4/8) 
levels were not detectable by Western blot in asynchronous undamaged cells, 
exacerbation of RS by low doses of UV radiation (10 Jm-2) elicited markedly greater 
phosphorylation of RPA32 in GSC than in paired tumor bulk populations (Figure 1C). 
Pulse labeling with BrdU revealed that RPA immunofluorescence intensity was 
significantly higher in S phase GSC than in tumor bulk cells in E2 and G7 cell lines; a 
trend towards higher intensity in R10 GSC narrowly failed to reach statistical 
significance (Figure 1D and E). While γ-H2AX foci are markers of DNA DSB, diffuse 
nuclear staining is also observed under conditions of RS (Supplementary figure 1C) 
(32, 33) with overall nuclear MFI correlating with levels of RS. In E2, G7 and R10 
cultures, S phase GSC demonstrated significantly higher γ-H2AX diffuse MFI than 
corresponding tumor bulk cells, providing further evidence of elevated RS (Figure 1D 
and E).  
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Exogenous replication stress can generate a radiation resistance phenotype in 
non-GSC 
The hypothesis that exogenous RS could stimulate the DDR and thus enhance 
radioresistance was tested by incubating bulk cultures of E2, G7 and R10 (which are 
radiosensitive relative to E2, G7 and R10 GSC cultures (12, 23) with 0.05 µM 
aphidicolin for 72 hours prior to irradiation. This low concentration of aphidicolin is 
known to slow DNA replication fork speed and generate RNA: DNA hybrids, leading 
to RS and DDR activation (34, 35) but was not sufficient to induce S phase arrest or 
affect plating efficiency in the absence of radiation in these experiments 
(Supplementary figure S2A i,ii). Exposure to 0.05 µM aphidicolin also generated an 
excess of pATM s1981 foci in exposed cell cultures versus controls, demonstrating 
the activation of DDR DNA DSB pathways by an exogenous source of RS 
(Supplementary figure S2A iii). Importantly, all bulk cell lines examined exhibited a 
significant increase in radioresistance after exposure to low dose aphidicolin, 
confirming that exogenously induced RS can generate measurable radiation 
resistance in vitro (Figure 1F). Survival curves for DMSO versus aphidicolin treated 
irradiated cells were significantly different in all cell lines and dose modifying factors 
(DMF) at 0.37 survival (and 95% confidence intervals) were 0.83 (0.76, 0.9), 0.80 
(0.68, 0.92), 0.82 (0.52, 1.12) in the E2, G7 and R10 cell lines respectively 
(Supplementary figure S2A iv). Surviving fractions at 2 Gy (SF2 Gy) are plotted in 
Supplementary figure S2A v. 
Replicating GSC show altered cell cycle progression and increased replication 
stress in vitro 
Cell cycle studies demonstrated significantly higher proportions of S phase cells in 
GSC than in tumor bulk populations (Figure 2A), despite GSC cultures having similar 
proliferation rates to tumor bulk cultures as shown in previous work (12), indicating 
that GSC have a prolonged S phase duration. A likely explanation is that GSC have 
slower DNA replication velocity than tumor bulk populations because of elevated RS.   
 
We confirmed elevated RS levels in GSC using the ‘gold standard’ DNA fiber assay 
(Figure 2B, C, D) in which immunofluorescent staining of sequentially incorporated 
nucleotide analogues CIdU (red) and IdU (green) facilitates visualization of DNA 
replication structures and direct measurement of DNA replication velocities (Figure 
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2B). GSC cultures exhibited significantly slower DNA replication velocities than 
matched tumor bulk populations (Figure 2B), as well as higher percentages of stalled 
replication forks and fewer ongoing forks, all of which are consistent with increased 
RS (Figure 2C). GSC cultures also showed a consistent trend towards a higher 
percentage of new origin replication structures, however this only reached 
significance in the G7 cell line. To exclude the possibility that these observations 
were caused by GSC culture conditions, we repeated the assay utilising cell 
populations which were sorted using the putative GSC markers CD133 and CD15. 
CD133+ (GSC) and CD133- (non GSC) sorted E2 cells when cultured in identical 
conditions for several passages, maintained GSC and non-GSC (bulk) phenotypes 
respectively. Importantly, CD133+ cells exhibited reduced replication velocity, 
increased frequency of stalled forks and fewer ongoing forks than their CD133- 
counterparts. Studies in the G7 cell line examining CD15+ GSC and CD15- non-
GSC cell sorted populations confirmed these findings. Further quantitative analyses 
of bidirectional fork replication structures in the E2 cell line supported our hypothesis. 
Bidirectional forks represent DNA replication arising from a single origin and 
proceeding in two opposing directions. In the absence of RS both forks proceed at 
the same velocity, leading to symmetrical green IdU tracks flanking a central red 
CIdU origin (Figure 2D) i.e. IdU1/IdU2 ≈ 1. E2 GSC exhibited a greater proportion of 
asymmetric versus symmetric bidirectional replication forks (Figure 2D) in 
comparison to E2 bulk cultures (asymmetry defined as >33% difference in length 
between bidirectional elongating IdU fibers i.e. IdU1/IdU2 ≥ 1.33 (36)). This effect 
was also observed in E2 CD133+ versus CD133- sorted cell populations (Figure 2D). 
Linear regression of long versus short track length showed significantly different 
gradient values for E2 GSC versus bulk cells and for E2 CD133+ versus CD133- 
cells (Figure 2D). Taken together our results show that RS in GSC is associated with 
reduced DNA replication velocity and higher rates of fork stalling.  
 
GSC exhibit increased numbers of γ-H2AX foci, which co-localize with 
replication factories and RNA: DNA hybrids 
Reduced DNA fork speed and other evidence of elevated RS led us to hypothesize 
that S phase GSC would harbor elevated numbers of DNA DSBs as a direct 
consequence of perturbed DNA replication. Consistent with this hypothesis, S phase 
GSC identified by BrdU incorporation had significantly more 53BP1 nuclear foci than 
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tumor bulk cells (Figure 3A). γ-H2AX foci were also more numerous in S phase GSC 
than tumor bulk cells (Figure 3B). Furthermore, in S phase GSC cultures, γ-H2AX 
foci co-localized with areas of intense BrdU staining, which represent concentrations 
of replication forks and their associated DNA replication machinery and have been 
described as ‘replication factories’ (37). Co-localization of γ-H2AX and BrdU foci was 
significantly higher in GSC than tumor bulk cells (Figure 3C), confirming formation of 
DNA DSBs during aberrant DNA synthesis and providing a likely explanation for 
constitutive DDR activation in GSC.  
 
To explore potential mechanisms responsible for elevated RS in GSC we analyzed 
changes in global gene expression profile between paired GSC and tumor bulk cells 
derived from 7 primary GBM cell lines using high throughput RNA sequencing. We 
first investigated if genes associated with DNA replication and/or the cellular 
response to RS were responsible for elevated RS in GSC. For this purpose, 
expression levels of genes encoding proteins known to be enriched on nascent DNA 
during unperturbed replication (‘replication machinery’ genes) and under conditions 
of RS induced by exposure to hydroxyurea (‘HU stalled forks’ genes) from previously 
published lists were examined in GSC and bulk cell populations (35). Overall, no 
significant differences in expression of ’replication machinery’ or ‘HU stalled fork’ 
genes were observed between GSC and tumor bulk cells (Supplementary figure S2B 
i,ii). Indeed only 2 of 82 transcribed ‘replication machinery’ genes and 4 of 131 
transcribed ‘HU stalled fork’ genes showed greater than 2.5 fold differential 
expression between GSC and bulk cells. From these data we concluded that altered 
expression of genes associated with nascent DNA was unlikely to be responsible for 
elevated RS in GSC.  
 
Given that aphidicolin could generate radiation resistance in our non-GSC primary 
GBM cultures (Figure 1F) and is known to generate RNA: DNA hybrids, we next 
investigated the hypothesis that the RS phenotype and its accompanying DDR might 
be associated with replication-transcription machinery collisions with subsequent 
common fragile site (CFS) breakage. CFS are chromosomal loci with an increased 
tendency to develop DNA DSBs under conditions of RS and occur preferentially 
within very large genes (VLG) that are transcriptionally active (35, 38, 39). RNA 
sequencing data revealed that 14 out of 73 VLGs (>850 Kbp in length) demonstrated 
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a 2.5 fold or greater expression in GSC relative to tumor bulk cells (Figure 3D), and 
that 9 of these genes were significantly overexpressed compared to paired bulk 
populations across all 7 cell lines (Figure 3D). If VLGs are defined more stringently 
as being greater than 1 Mbp in length, the association remained significant: 
expression of 5 out of 31 genes >1 Mbp was > 2.5 fold greater in GSC than bulk 
cells, of which 3 were significantly overexpressed across all 7 cell lines (Figure 3E). 
These include: deleted in colorectal carcinoma (DCC), cell adhesion molecule 2 
(CADM2) and protein tyrosine phosphatase receptor type T (PTPRT); which have 
been shown to play important roles in the regulation of neurological development, 
axon guidance and synapse formation (40-42). In order to investigate the 
contribution of replication transcription collisions to DNA DSB generation in GSC, 
immunofluorescent staining for RNA: DNA hybrids (S9.6) and γ-H2AX was carried 
out and co-localization studies were performed. These data demonstrated significant 
co-localization and overlap of γ-H2AX foci with areas of intense S9.6 
immunofluorescence in E2 and G7 GSC populations, suggesting a prominent role for 
replication transcription collisions as a source of DNA DSBs in GSC (Figure 3F, G).  
Consistent with these findings, a recent study by Wei et al demonstrated that long 
neural genes harbor recurrent DNA break clusters in neural stem/progenitor cells 
(20). In addition, a further study has identified intragenic DNA origin firing in highly 
transcribed genes with consequent replication-transcription collisions as a 
mechanism for oncogenic RS (43). Although much debated, neural progenitor cells 
have been proposed as a cell of origin for GBM (44). Therefore the description of RS 
induced DNA DSB formation in transcriptionally active long neural genes in neural 
progenitor cells and the role of intragenic origins in generating oncogenic RS are 
highly relevant to our own data in GSC. We propose that replication-transcription 
collisions due to active transcription of long neural genes in GSC is responsible for 
the elevated RS in GSC, resulting in generation of DNA DSBs, constitutive DDR 
activation and consequent therapeutic resistance.  
 
GSC show enhanced replication stress in murine intracranial orthotopic 
xenografts and in human GBM tumor samples 
Having observed compelling evidence of increased RS in GSC in vitro, we 
investigated whether this phenotype was also present in vivo. Dual 
immunofluorescent staining for RPA32 and the putative GSC marker Sox2 was 
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undertaken in sections of orthotopic xenograft tumors derived from CD133+ E2 GSC, 
which generate highly invasive, diffuse tumors and in tumors derived from G7 GSC 
which form a tumour mass with an invasive front typical of human GBM (Figure 4A, 
B and Supplementary Figure S3A-E). Our data showed  a higher MFI of RPA32 
staining in high (defined as greater than median) Sox2 expressing cells relative to 
low (less than median) Sox 2 expressing cells, consistent with the presence of 
elevated RS levels in the GSC subpopulation. MFI values of Sox2 and RPA32 also 
showed a significant positive correlation (Figure 4A, B). Further studies in G7 GSC 
and CD133+ E2 xenografts confirmed increased RS in GSC, utilising alternative 
GSC (Olig2) and RS (PARP-1) markers (Supplementary Figure S4 A-C). 
 
Further immunohistochemical staining for HLA, RPA32, Ki67 and H2AX was 
performed in sections of xenografts derived from CD133+ E2 GSC in which the 
majority of HLA expressing tumor cells stained strongly positive for the GSC marker 
Sox2, (Supplementary Figure S3A, D). Tumour sections also exhibited widespread 
positivity for Ki67, RPA32 and γ-H2AX nuclear staining, indicating high levels of RS 
in replicating GSC in vivo.  
 
To confirm the clinical relevance of these observations, dual immunofluorescence 
staining for Sox2 and RPA32 was performed in human tumor sections from four 
GBM patients (Figure 4C and Supplementary figure S5A-D). Consistent with our 
earlier xenograft studies (Figure 4A and 4B), MFI of RPA32 was significantly higher 
in cell populations which exhibited greater than median MFI of Sox2 (Figure 4C). 
This observation was reproduced using Olig2 as a GSC marker (Supplementary 
figure S5D). RPA32 and Sox2 expression also showed significant positive correlation 
in all tumors examined (Supplementary figure S5A-C).   
 
Inhibition of the RS response in GSC reduces neurosphere formation, 
generates DNA DSBs and abrogates radiation resistance 
Our data indicate that constitutive RS represents a promising, GSC specific 
therapeutic target in GBM, which is a cancer of unmet need. To validate this concept 
we used olaparib, a small molecule inhibitor of poly (ADP-ribose) polymerase 
(PARP) currently in clinical trials for GBM, and VE821, a potent and specific inhibitor 
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of ATR (45), to target key elements of the DDR and RS responses. PARP1 facilitates 
restart of stalled replication forks (46) while ATR has a key role in enabling cells to 
tolerate RS via activation of cell cycle checkpoints, inhibition of global origin firing 
and stabilization of stalled replication forks. Inhibition of ATR (5 μM VE821) 
significantly inhibited neurosphere formation in all three GSC populations tested 
whereas inhibition of PARP (1 μM olaparib) had little or no effect (Figure 5A). 
However, addition of olaparib to VE821, (Combined ATR inhibition and PARP 
inhibition; ‘CAiPi’) yielded significant, supra-additive inhibition of neurosphere 
formation, which is a fundamental property of GSC that requires proliferation and 
self-renewal. Since tumor bulk cultures do not form neurospheres, cell viability 
assays were undertaken to enable comparison of the effects of CAiPi on paired GSC 
and tumor bulk cultures. Consistent with our hypothesis that RS is an integral and 
targetable characteristic of GSC, these populations were significantly more sensitive 
to CAiPi than tumor bulk cells (Figure 5B). Addition of PARPi to GSC or bulk cultures 
did not affect DNA replication velocities at the clinically relevant concentrations 
examined, whereas addition of ATRi or CAiPi reduced replication velocities in both 
GSC and bulk (Figure 5C). Further mechanistic studies in E2 cells showed increased 
induction of γ-H2AX foci and micronuclei (Figure 5C) in GSC by CAiPi, supporting 
the concept that higher basal RS in GSC renders them particularly vulnerable to 
increased DNA damage and consequent cell death when subjected to inhibition of 
the DDR. Furthermore, and of profound clinical relevance, clonogenic survival 
assays revealed that CAiPi completely abrogated the radioresistance of GSC (Figure 
5D), yielding sensitizer enhancement ratios at 37% survival of between 2 and 3.6. 
The radiosensitizing effect of the combination was significantly greater in GSC than 
in bulk cells when SER 0.37 values were compared (Figure 5D). Of note, R10 GSC 
were not radiosensitized by olaparib alone, however combined ATR and PARP 
inhibition resulted in potent radiosensitization. γ-H2AX foci analyses confirmed that 
CAiPi generates an excess of DNA DSBs in GSC in combination with radiation, 
(Figure 5D iv). 
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Discussion  
Radiation resistance of GSC is a well-recognized yet poorly understood 
phenomenon, comprehension of which is vitally important to attempts to improve the 
therapeutic index of current therapy for GBM, since improvements in patient survival 
depend upon our ability to control or eradicate this tumor cell fraction. Despite 
characterization of up regulated DDR in cancer stem cells of different tumor types, 
the underlying reason for activated DDR and consequent radiation resistance in 
GSC has remained elusive. Given the ubiquity of this phenotype in GSC and its 
prevalence in cancer stem cells of other tumor types, deeper understanding of the 
responsible mechanisms is predicted to generate highly appealing targets for clinical 
therapy. 
  
RS has previously been implicated in the evolution of GBM and other cancers, 
particularly with regard to oncogene-induced senescence and as an anticancer 
barrier in early tumorigenesis (14, 47-49). Indeed, a recent study has suggested 
reliance upon the BRCA1-RRM2 axis for protection from RS in GBM (50). These 
studies validate that RS is a general feature of GBM, and may result in activated 
DDR in the tumor as a whole, however do not address whether RS is of particular 
importance in GSC, or the role of RS in determining DDR activation in GSC and 
have not shown that RS is responsible for radiation resistance. RS has recently been 
documented in non-malignant embryonic stem cells, which display constitutively 
active DDR and prolonged S phase occupancy due to abnormal cell cycle 
progression. These features rapidly diminish upon differentiation (9). Our data 
provide novel insights into the importance of RS in the GSC phenotype and direct 
evidence that RS is responsible for the activation of DDR and subsequent radiation 
resistance in GSC.  
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Furthermore, we identify replication transcription collisions as a result of increased 
expression of long neural genes as a likely mechanism for RS in GSC, an 
observation that correlates closely with recently published studies in neural 
progenitor cells which demonstrate that DSB arising from replication stress are 
preferentially located in long neural genes (20). Indeed, several of these genes, 
namely DCC, CADM2 and PTPRT are significantly overexpressed across a panel of 
7 GSC cultures. A further study of particular relevance to our data has recently 
described a novel mechanism for oncogenic RS dependent upon intragenic origin 
firing within highly transcribed genes (43). Taken together these data support the 
controversial hypothesis that GSC derive from neural stem cells and provide grounds 
for further studies.  
Finally we show that RS responses in GSC can be specifically targeted via dual 
inhibition of the key DDR and RS response proteins PARP and ATR. Our data 
demonstrate that GSC are significantly more sensitive to RS response targeting than 
non-GSC because of increased DNA DSB formation in GSC. Interestingly, GSC 
were also sensitized to radiation by dual ATR-PARP inhibition to a significantly 
greater degree than non-GSC, further validating our hypothesis that the radiation 
resistance of GSC is highly dependent on RS. Our results also suggest the feasibility 
of DDR targeting agents as promising therapies for GBM, both alone and in 
combination with radiotherapy. 
Overall, our observations elucidate for the first time the mechanism underlying DDR 
activation and radioresistance in GSC, support a NSC origin for GSC and identify RS 
response as a GSC specific therapeutic target with the potential to improve patient 
outcomes from GBM. 
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Figure 1  
Radioresistant GSCs demonstrate up regulation of DNA RS response markers, 
and exogenous RS generates radiation resistance in non-GSCs  
 
A Western blot analysis of RS response and GSC markers in a panel of paired GSC 
and tumor bulk primary GBM cultures. GAPDH loading control. B Flow cytometry 
plots showing baseline levels of reactive oxygen species (ROS) via quantification of 
DCFHDA mean fluorescence intensity (MFI) in GSC and tumor bulk cultures (mean 
+/- SEM, n=3, unpaired t-test, NS=non-significant), C Western blot analysis of 
phospho-RPA32 (Ser4/8) expression in a panel of paired GSC and tumor bulk cells 
following UV mediated activation of RS (10Jm-2). D Immunofluorescence images 
showing γ-H2AX and RPA32 staining in BrdU positive G7 GSC and tumor bulk cells 
under basal conditions. Nuclei are counterstained with DAPI. E Quantification of γ-
H2AX and RPA32 MFI in E2, G7 and R10 GSC and tumor bulk cells, (mean +/-SEM, 
n = 3, *p<0.05, **p < 0.01, unpaired t-test). F Clonogenic survival of E2, R10 and G7 
tumor bulk cell lines treated with radiation alone (blue line) and following incubation 
with 0.05µM aphidicolin (red line) for 72 hours prior to irradiation (mean +/-SEM, n = 
3 **p<0.01, ****p<0.001 by two way ANOVA). Representative images of colonies 
formed following 0, 2 and 4 Gy are shown.  
 
 
Figure 2 
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Replicating GSCs show altered cell cycle phase progression and enhanced 
replication stress in vitro 
 
A Representative flow cytometry plots and analysis of S-phase populations in R10 
and R15 GSC and tumor bulk cells by quantification of BrdU incorporation under 
basal conditions (mean +/-SEM, n = 3, * p<0.05, unpaired t-test). B Schematic of 
DNA fiber assay; cells were incubated sequentially with CIdU (red) then IdU (green) 
followed by lysis and spreading. Representative immunofluorescent images of DNA 
fibers obtained from E2 GSC and bulk cells. Bar charts summarize quantification of 
IdU and CIdU incorporation rates (replication velocities) in GSC and tumor bulk cells 
in E2, G7 and R15 cell lines and in E2 CD133+ and CD133- populations and G7 
CD15+ and CD15- populations, (mean +/-SEM,  n=3, ≥ 500 ongoing replication forks 
analyzed per data point, *p<0.05, unpaired t-test). C Representative 
immunofluorescent images showing ‘new’, ‘ongoing’, ‘stalled’ and ‘bidirectional’ 
replication fork structures following sequential pulse labeling with CIdU (red) and IdU 
(green) in E2 GSC cultures. Bar charts summarize quantification of stalled, ongoing 
and new replication forks (as a percentage of total number of replication structures 
identified) in paired GSC and bulk cultures of E2, R15 and G7 cell lines and also in 
E2 CD133+ and CD133- and G7 CD15+ and CD15- sorted populations. (Mean +/-
SEM, unpaired t test, with approx. 1800 replication forks identified and counted for 
each cell line, n ≥ 3). D Schematic showing symmetric and asymmetric bidirectional 
DNA replication fork structures observed in DNA fiber assay. Analysis of bidirectional 
replication fork ratio in E2 GSC and bulk cultures and also in E2 CD133+ and 
CD133- sorted populations. Each point represents an individual bidirectional 
replication fork, with longer IdU (green) track plotted on y axis versus shorter IdU 
track on x axis. Plotted solid black line represents a ratio of ‘1’ (i.e. no asymmetry), 
whilst plotted dotted black line represents a ratio of ≥ 1.33 (i.e. asymmetry). Table 
shows gradient of best-fit linear regression lines (95% CI) of long IdU versus short 
IdU tracks in paired E2 GSC and bulk and in E2 CD133+ and CD133- populations. 
 
Figure 3 
GSCs demonstrate increased numbers of γ-H2AX foci, which co-localize with 
replication factories and RNA: DNA hybrids 
A-B Representative immunofluorescence images of G7 GSC and tumor bulk cells 
showing (A) 53BP1 and (B) γ-H2AX  foci in BrdU positive cells under basal 
conditions, with quantification of (A) 53BP1 and (B) γ-H2AX foci per S-phase 
nucleus in G7 and E2 GSC and tumor bulk cells (mean +/-SEM, n = 3, *p<0.05, 
**p<0.01). C Representative images demonstrating co-localization of γ-H2AX foci 
with BrdU replication factories (BrdU foci) in G7 GSC and tumor bulk cells. 
Percentages of BrdU positive replication factories co-localizing with γ-H2AX foci are 
quantified in E2 and G7 GSC and tumor bulk cells (mean +/-SEM, n=3, *p<0.05, 
**p<0.01, unpaired t-test). D Mean fold change in the expression of genes across 7 
GSC cultures compared to the paired tumor bulk cells associated with genes >850kb 
in length. Numbers of genes identified from the RNA sequencing data and total 
numbers of genes in the published gene dataset is shown in brackets and total 
numbers of up-and down regulated genes are indicated in boxes. The numbers and 
percentages of significantly altered (‘Sig’) genes in each dataset are shown and 
these genes are highlighted in red. Gene shown in blue was up regulated 24-fold. 
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Mean fold changes across all genes are shown by red lines. Genes >850bp in length 
are significantly up regulated in GSC compared to paired tumor bulk population 
across 7 GBM cell lines (one sample t-test, *p<0.05, NS=non-significant). E 
Heatmap illustrating fold changes in expression of the 9 significantly up regulated 
genes >850bp across 7 paired cell lines. F Representative image of 
immunofluorescent staining for RNA: DNA hybrids using S9.6 antibody and γ-H2AX 
in E2 GSC.  G Table of colocalization and overlap coefficients (95% CIs) for γ-H2AX 
versus S9.6 immunofluorescence in E2 and G7 GSC. 
 
 
 
 
Figure 4 
GSCs show enhanced replication stress in murine intracranial orthotopic 
xenografts and in human GBM tumor samples 
 
A and B Representative images (63x magnification) of immunofluorescent staining 
for RPA32 and Sox2 in sections from murine orthotopic intracranial xenografts 
derived from A E2 CD133+ cells and B G7 GSC cultures. Scatter plots showing 
correlation between Sox2 and RPA32 MFI, with corresponding r values (95% CI). 
Bar charts show RPA32 MFI quantified in Sox2 low and Sox2 high populations 
(defined as below and above median Sox2 MFI intensity values respectively; mean 
+/-SEM, unpaired t test). C Representative images (63x magnification) of 
immunofluorescent staining for RPA32 and Sox2 in a section from a resected human 
GBM tumor ‘15 1170.’ Scatter plot showing correlation between Sox2 and RPA32 
MFI, with corresponding r value (95% CI). Bar chart shows RPA32 MFI quantified in 
Sox2 low and Sox2 high populations, (defined as above and below median Sox2 MFI 
values respectively; mean +/-SEM, unpaired t test) in 4 different resected human 
GBM specimens. 
 
Figure 5 
Inhibition of RS response inhibits GSC neurosphere formation, generates DNA 
DSBs and abrogates GSC radiation resistance 
A Neurosphere formation by E2, G7 and R10 GSCs following 48 hour exposure to 
PARPi (1μM) or ATRi (5μM) alone, CAiPi or radiation (2Gy). Surviving neurosphere 
fraction is plotted relative to DMSO control (mean+/-SEM, n=3, *p<0.05, **p<0.01, 
***p<0.001, unpaired t-test). B Cell viability of paired E2 and R10 GSC and tumor 
bulk cultures following 24 hour incubation with PARPi alone (1μM), incremental 
concentrations of ATRi alone (1, 3 and 5 μM) or CAiPi.  (Mean +/-SEM, n=3, 
***p<0.001 unpaired t-test). Ci Quantification of CIdU and IdU incorporation rates 
(replication velocities) in E2 GSC and bulk following 24 hour exposure to PARPi 
(1μM) or ATRi (5μM) alone or CAiPi as measured by DNA fiber assay (mean +/- 
SEM, n = 3, unpaired t test. ii Quantification of mean γ-H2AX foci per nuclei and 
micronuclei formation in E2 GSC and tumor bulk cells following 48 hour exposure to 
ATRi or PARPi alone or CAiPi relative to DMSO control (mean+/-SEM, n=3, 
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**p<0.01, unpaired t test). Di Clonogenic survival curves derived from R10 GSCs 
following exposure to DMSO, ATRi or PARPi or CAiPi for 1 hour pre and 24 hours 
post ionizing radiation (0-5Gy) (mean+/SEM, n = 3). ii Clonogenic survival curve 
derived from R10 GSC and paired R10 bulk following treatment with DMSO or 
combined ATRi and PARPi with radiation. iii Quantification of radiation sensitizer 
enhancement ratios for 0.37 survival following combined ATRi/PARPi in E2 and R10 
GSC and bulk (n≥3, mean +/- SEM). iv Quantification of median  γ-H2AX foci per 
nucleus in E2 GSC and bulk cells following exposure to CAiPi or DMSO for 1 hour 
pre and 24 hours post irradiation with 2Gy or sham irradiation. (median +/- range, n = 
1, *p<0.05, **p<0.01, Mann Whitney U test). 
 
 
 





